Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

189.31 -0.94 (-0.50%)
Streaming Delayed Price Updated: 9:31 AM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quest Diagnostics

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Analyst Expectations for Quest Diagnostics's Future ↗
 
Via Benzinga
News headline image
Is This Healthcare Stock a Buy for Dividend Growth Investors? ↗
This maker of diagnostics tests just announced that it will be sending more cash to its shareholders. 
Via The Motley Fool
News headline image
2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7% ↗
These companies may not be finished raising their dividend payments as they both have low payout ratios. 
Via The Motley Fool
5 Analysts Have This to Say About Quest Diagnostics ↗
 
Via Benzinga
News headline image
Down 40% in 2022, Can Exact Sciences Recover in 2023? ↗
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous. 
Via The Motley Fool
News headline image
Analyst Ratings for Quest Diagnostics ↗
 
Via Benzinga
News headline image
These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to 5% 
Via Benzinga
Where Quest Diagnostics Stands With Analysts ↗
 
Via Benzinga
Golden Cross Appears Before Quest Diagnostics Investors ↗
 
Via Benzinga
Where Quest Diagnostics Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Quest Diagnostics Stock Jumped Today ↗
Growth in the lab testing titan's core business is accelerating. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023 ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Quest Diagnostics Q3 Earnings Surpass Expectations, Raises Annual Guidance ↗
 
Via Benzinga
News headline image
Quest Diagnostics Lifts Annual Guidance On Higher COVID-19 Test Revenue Anticipation ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday ↗
 
Via Benzinga
News headline image
Quest Diagnostics: Q3 Earnings Insights ↗
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 20, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For October 20, 2022 ↗
Companies Reporting Before The Bell • ABB (NYSE:ABB) is estimated to report quarterly earnings at $0.38 per share on revenue of $7.35 billion. 
Via Benzinga
News headline image
A Preview Of Quest Diagnostics's Earnings ↗
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the announcement. Analysts estimate that Quest... 
Via Benzinga
News headline image
Eli Lilly, EQT, Cash Cows ETF, Northrop Grumman And This Diagnostics Company Feature On CNBC's Final Trade ↗
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS: COWZ) is “a factor-b 
Via Benzinga
News headline image
What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day ↗
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined... 
Via Benzinga
News headline image
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗
 
Via Benzinga
News headline image
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
News headline image
Quest Becomes Exclusive Validator For Results From The Hound Cannabis Breathalyzer ↗
Hound Labs, creator of the Hound Cannabis Breathalyzer, entered into an agreement with Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services. 
Via Benzinga
News headline image
No More Free COVID-19 At-Home Tests, Federal Government Says ↗
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
News headline image
3 Top Monkeypox Stocks to Buy Right Now ↗
With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now. 
Via InvestorPlace
News headline image
3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency ↗
Monkeypox stocks are about to rise now that the White House has declared the virus a public health emergency. Here are the stocks to watch. 
Via InvestorPlace
News headline image
Drug Testing At Work Is A Thing Of The Past, Study Finds ↗
According to a study conducted by Quest Diagnostics Inc (NYSE: DGX), drug use among American employees, as measured by the percentage of employees who tested positive in urine drug tests, hit a 
Via Benzinga
News headline image
4 Analysts Have This to Say About Quest Diagnostics ↗
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.